Hepatitis B, Chronic: all 954 studies
Page 9 of 10. Open to participants first (147), then studies with results posted, then the rest; newest registration first within each.
- PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B PatientsCompletedNCT01373684Phase 4
- Prediction of Incidence of Liver Cancer by Use of Real-time Tissue ElastographyStatus unknownNCT01360892
- Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver DiseaseStatus unknownNCT01360879
- Persistence, Adherence and Clinical Effectiveness of Entecavir in Chronic Hepatitis B PatientsCompletedNCT01356901
- Lamivudine and Adefovir Dipivoxil Fixed Dose CombinationCompletedNCT01353742Phase 1
- Efficacy of Medical Ozone Therapy in Patients With Chronic Hepatitis BStatus unknownNCT01342185Phase 3
- Efficacy Optimizing Research of Chronic Hepatitis B Patients With Inadequate Response to NUC TherapyStatus unknownNCT01341743Phase 4
- Induction of Fibrosis Regression on Patients With Chronic Hepatitis B InfectionTerminatedNCT01341106Phase 4
- Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase LevelsCompletedNCT01337791Phase 4
- Entecavir for Chronic Hepatitis BCompletedNCT01323452
- Hepatitis B Virus Mutants and the Therapeutic Effect of Peginterferon Alfa-2a in HBeAg-Positive Chronic Hepatitis BCompletedNCT01311947
- The Development of Diagnostic Biomarker Panels for Hepatitis and Liver CancerStatus unknownNCT01310062
- An Observational Study of Pegasys (Peginterferon Alfa-2a) in Patients With HbeAg-negative Chronic Hepatitis B (Perseas)CompletedNCT01283074
- Entecavir for Chronic Hepatitis B in Hepatocellular Carcinoma Patients Underwent Radiofrequency Ablation TherapyStatus unknownNCT01270178
- Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis BStatus unknownNCT01270165Phase 3
- Long-term Study on Anti-HBV Effect of Tenofovir and Resistance Surveillance in Asian-American Adult PatientsCompletedNCT01267162
- A Study to Compare and Evaluate Intrahepatic cccDNA Reduction After Administrating Clevudine or Entecavir in the Chronic HBV PatientsTerminatedNCT01266005Phase 4
- A Study to Evaluate the Efficacy and Safety of Clevudine and Peg-interferon in Sequence Compared With Clevudine Alone in the Patients With HBeAg(+) Chronic Hepatitis B or Clevudine and Peg-interferon Sequential Treatment in Patients With Chronic Hepatitis B Who Have HBeAg(+)CompletedNCT01264367Phase 4
- An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BCompletedNCT01264354Phase 4
- A Study With Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis BTerminatedNCT01264133Phase 4
- An Open Study to Evaluate the Sustained Effect in Patients Showing Virological Responses With Muscle-related Symptom of Chronic Hepatitis B Patients Who Received ClevudineCompletedNCT01264107
- A Study to Evaluate the Efficacy and the Change of sAg Levels in Chronic Hepatitis B Patients Receiving Clevudine Treatment Over the Long PeriodTerminatedNCT01264094Phase 4
- Randomized Controlled Study of Tenofovir Plus Telbivudine Versus Monotherapy With Either Drug in HBeAg Negative Chronic Hepatitis B PatientsWithdrawnNCT01260610Not applicable
- The Efficacy and Safety of Entecavir Treatment of Patients With Acute on Chronic Hepatitis B Liver FailureCompletedNCT01254994Phase 2
- Pegylated Interferon Alpha-2b Monotherapy Versus Combination With Entecavir in HBeAg-negative Chronic Hepatitis BStatus unknownNCT01243281Not applicable
- Long-term Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BStatus unknownNCT01242787Phase 2
- Analysis of HBV-Specific Immune Response in Patients With HBeAg Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a (40KD)) - Immunology Sub-Study of ML18253CompletedNCT01237496Phase 3
- Efficacy Study of Sequential Therapy of Peginterferon Alfa-2a Following Entecavir in Patient With Chronic Hepatitis B.Status unknownNCT01220596Phase 3
- A Study of FG-3019 in Subjects With Liver Fibrosis Due to Chronic Hepatitis B InfectionTerminatedNCT01217632Phase 2
- Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath TestWithdrawnNCT01204827Phase 2/3
- Treatment on HBeAg Positive or HBeAg Negative in Chronic Hepatitis BApproved for marketingNCT01198860
- An Study of Efficacy and Safety of ClevudineCompletedNCT01192854Phase 3
- A Clinical Study on Therapeutic Double-plasmid Hepatitis B Virus (HBV) DNA Vaccine in Patients With HBeAg-positive Chronic Hepatitis BStatus unknownNCT01189656Phase 2
- A Study of 48 Versus 96 Weeks of Peginterferon Alfa-2a [Pegasys] Treatment, With or Without Entecavir, in Patients With Chronic Hepatitis B.WithdrawnNCT01179594Phase 4
- A Randomized Study to Assess the Loss of HbsAg After a 48-week Treatment Period With Pegylated Interferon Alpha 2a in Patients With Chronic Hepatitis BStatus unknownNCT01172392Phase 3
- Epidemiological Study in Children and Adolescents With Chronic Hepatitis BCompletedNCT01163240
- Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)CompletedNCT01155427
- Influence of Hepatic Steatosis on the Therapeutic Effect of Entecavir in Chronic Hepatitis B PatientsStatus unknownNCT01148576Phase 4
- Efficacy and Safety of Ypeginterferon Alfa-2b in HBeAg Positive Chronic Hepatitis BCompletedNCT01143662Phase 2
- Lamivudine(LAM) Good Responder StudyCompletedNCT01128686
- Observe Change of Endotoxaemia and Related Mediators in Patients With Chronic Hepatitis B Virus (HBV) InfectionCompletedNCT01107483
- Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral TherapyStatus unknownNCT01090531
- Efficacy Optimizing Research of Lamivudine TherapyCompletedNCT01088009Phase 4
- A Study of Peginterferon Alfa-2a [PEGASYS] in Patients With Chronic Hepatitis B Who Are HBeAg PositiveCompletedNCT01086085Phase 4
- Health Promotion and Management for Hepatitis B CarriersStatus unknownNCT01065363Not applicable
- Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine TherapyCompletedNCT01037166Phase 2
- An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B InfectionCompletedNCT01037062Phase 2
- Dose Escalation of Interleukin-1 (IL-7) Added on Antiviral Treatment and Vaccination in HBeAg-negative Chronic Hepatitis B Virus (HBV) Infected PatientsStatus unknownNCT01027065Phase 1/2
- Safety and Efficacy Study of LB80380 in the Treatment-naive Patients of Chronic Hepatitis BCompletedNCT01026610Phase 2
- A Study to Assess DV-601 in Subjects With Chronic Hepatitis BCompletedNCT01023230Phase 1
- A Phase II Dose Response Study in Japan in Chronic Hepatitis BCompletedNCT01022801Phase 2
- A Study in Japan of the Safety and Antiviral Activity With Chronic Hepatitis B InfectionCompletedNCT01020565Phase 2
- Lamivudine Therapy in Patients With Prior Entecavir Treatment and Undetectable Viral LoadCompletedNCT01013272Not applicable
- Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With TelbivudineTerminatedNCT01005238Phase 4
- Simvastatin for the Treatment of Chronic Hepatitis BCompletedNCT00994773Phase 1
- Safety and Immunogenicity of a Naked DNA-based Vaccine Therapy in Patients With Chronic Hepatitis BCompletedNCT00988767Phase 1
- Entecavir Plus Adefovir in Lamivudine-Resistant PatientsWithdrawnNCT00986778Phase 4
- Continue Entecavir Rollover From ChinaCompletedNCT00975091Phase 3
- Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral LoadCompletedNCT00973219Not applicable
- Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection SubjectsTerminatedNCT00964665Phase 1/2
- A Study of Pegasys Monotherapy in Patients With Chronic Hepatitis B Who Have Participated in Previous StudiesCompletedNCT00962975Phase 1
- EFFicacy Optimization Research of Telbivudine TherapyCompletedNCT00962533Phase 4
- Therapeutic Effects of Liver Failure Patients Caused by Chronic Hepatitis B After Autologous MSCs TransplantationCompletedNCT00956891
- Efficacy and Safety Study of Telbivudine to Prevent Perinatal TransmissionStatus unknownNCT00939068Phase 4
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Positive Chronic Hepatitis BStatus unknownNCT00921180Phase 4
- Entecavir and Pegasys Sequential Therapy Versus Pegasys for HBeAg Negative Chronic Hepatitis BStatus unknownNCT00917761Phase 4
- Pharmacokinetics and Safety of Single-Dose Telbivudine in Children and Adolescents With Chronic Hepatitis BCompletedNCT00907894Phase 1
- Efficacy and Safety of Intramuscular HBIG Grifols for the Prevention of Recurrence After Liver TransplantationCompletedNCT00895713Phase 2
- Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis BCompletedNCT00895596Phase 1/2
- PEG-IFN in HBV Patients With Incomplete Response to NACompletedNCT00883844Phase 4
- Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis BCompletedNCT00877760Phase 4
- Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis BCompletedNCT00877149Phase 4
- Efficacy of Telbivudine in Blacks/African Americans and Hispanics/Latinos With Compensated Chronic Hepatitis B During 52 WeeksWithdrawnNCT00862706Phase 4
- Early Response to Interferon Combined Short-Term Nucleoside Analogue Therapy in HBeAg(+) Chronic Hepatitis BStatus unknownNCT00860626Not applicable
- A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis BCompletedNCT00857675Phase 3
- Evaluation of Serum Levels and Pharmacokinetics of a New Hepatitis B Immune Globulin Following Liver TransplantationCompletedNCT00838071Phase 3
- Antiviral Therapy in Hepatitis B Virus (HBV)-Related Advanced Liver Disease PatientsStatus unknownNCT00823550Phase 4
- A Single-Arm Study Evaluating the Efficacy of Liquid Acupuncture Therapeutics in Chronic Hepatitis BStatus unknownNCT00815464Not applicable
- Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV InfectionStatus unknownNCT00810524Phase 4
- Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)CompletedNCT00804622Phase 2
- Nabi-HB Administered Subcutaneously in Patients With Hepatitis B Virus Post Liver TransplantationWithdrawnNCT00800787Phase 3
- Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B PatientsTerminatedNCT00798460Phase 4
- Efficacy and Safety of Telbivudine 600mg Tablets in Chinese Patients With Chronic Hepatitis BCompletedNCT00781105Phase 4
- Prednisolone Priming Study in Patients With Chronic Hepatitis BStatus unknownNCT00778596Phase 4
- A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis BStatus unknownNCT00753467Phase 2
- The Risk of Exacerbation of Chronic Hepatitis B After Percutaneous Radiofrequency Ablation of Hepatocellular CarcinomaStatus unknownNCT00720668
- Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B PatientsWithdrawnNCT00715715Not applicable
- Comparison of Telbivudine Versus Lamivudine on the Early Dynamics and Kinetics of Viral Suppression in Chronic Hepatitis BWithdrawnNCT00710216Phase 4
- ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis BCompletedNCT00661076Phase 3
- A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)CompletedNCT00651209Phase 4
- Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis BCompletedNCT00646503Phase 4
- CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation StudyCompletedNCT00645736
- A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver FunctionCompletedNCT00641082Phase 4
- Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With TelbivudineCompletedNCT00640588Phase 3
- Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable Hepatitis B Virus DNACompletedNCT00637663Phase 4
- Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With VasopressinStatus unknownNCT00635310Not applicable
- Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNACompletedNCT00625560Phase 4
- Continuing Lamivudine Versus Switching to Entecavir in Patients Who Achieved Undetectable HBV DNACompletedNCT00625339Phase 4
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.CompletedNCT00614471Phase 4
- Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis BWithdrawnNCT00606099Phase 4